Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.020 | 0.500 | 2 | 2015 | 2016 | |||||
Colorectal Carcinoma
|
1962 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.020 | 0.500 | 2 | 2015 | 2016 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Acute lymphocytic leukemia
|
222 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1 | 2011 | 2011 | ||||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1 | 2011 | 2011 | ||||||
Carcinoma of larynx
|
65 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1 | 2011 | 2011 | ||||||
Leukemia, Myelocytic, Acute
|
6892 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Liver carcinoma
|
942 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of lung
|
1142 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant Neoplasms
|
1641 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Myocardial Ischemia
|
103 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Nasopharyngeal carcinoma
|
320 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1 | 2011 | 2011 | ||||||
Neoplasms
|
1644 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Primary malignant neoplasm
|
1374 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Primary malignant neoplasm of lung
|
981 | 0.708 | 0.360 | 8 | 89935041 | 3 prime UTR variant | C/G | snv | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 |